| abstract |
There are disclosed aptamer ligands to MUC1, preferably comprising a sequence selected from:n nand compounds comprising these aptamers and sequences. There are also disclosed compounds having the structuren n There are also disclosed methods of treatment, diagnosis, detection and imaging using these compounds, their use in such methods, and their use in the preparation of medicaments and products for such methods. |